| Filed On | Filing |
|---|---|
| 28 Apr 2026 |
Proxy statement: annual meeting on June 18, 2026
CEO pay $4.9M, down 4.2% · say-on-pay vote |
| 28 Apr 2025 |
Proxy statement: annual meeting on June 20, 2025
CEO pay $5.1M, up 14% · say-on-pay vote |
| 11 Jun 2024 |
DEF 14A
CEO pay $4.5M, down 25% |
| 01 May 2023 |
DEF 14A
CEO pay $5.9M, up 41% |
| 27 Apr 2022 | DEF 14A |
| 30 Apr 2021 | DEF 14A |
| 29 Apr 2020 | DEF 14A |
| 25 Apr 2019 | DEFINITIVE PROXY STATEMENT |
| 17 Apr 2018 | DEF 14A |
| 28 Apr 2017 | DEF 14A |
| 20 Apr 2016 | DEFINITIVE PROXY STATEMENT |
| 23 Apr 2015 | DEFINITIVE ADDITIONAL MATERIALS |
| 23 Apr 2015 | DEFINITIVE PROXY STATEMENT |
| 23 Apr 2014 | DEFINITIVE PROXY STATEMENT |
| 23 Apr 2013 | ANIKA THERAPEUTICS, INC. DEF 14A |
| 25 Apr 2012 | ANIKA THERAPEUTICS, INC. DEF 14A |
| 28 Apr 2011 | ANIKA THERAPEUTICS, INC. DEF 14A |
| 22 Apr 2010 | ANIKA THERAPEUTICS, INC. DEF 14A |
| 28 Apr 2009 | DEF 14A |
| 25 Apr 2008 | DEF 14A |
Loading...
